Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Sentana Lledo, M.D.

Concepts (12)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Daniel Sentana Lledo's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniel Sentana Lledo has written about over time.
Cross-Sectional Studies, 1 publications between 2023 and 2023, average publication date February 2023. Morbidity, 1 publications between 2023 and 2023, average publication date February 2023. Prevalence, 1 publications between 2023 and 2023, average publication date February 2023. Prostatectomy, 1 publications between 2023 and 2023, average publication date February 2023. Quality of Life, 1 publications between 2023 and 2023, average publication date February 2023. Humans, 2 publications between 2023 and 2024, average publication date August 2023. Male, 2 publications between 2023 and 2024, average publication date August 2023. Prostatic Neoplasms, 2 publications between 2023 and 2024, average publication date August 2023. Androgen Antagonists, 1 publications between 2024 and 2024, average publication date February 2024. Androgens, 1 publications between 2024 and 2024, average publication date February 2024. Cardiovascular Diseases, 1 publications between 2024 and 2024, average publication date February 2024. Risk Factors, 1 publications between 2024 and 2024, average publication date February 2024.

To see the data from this visualization as text, click here.
Sentana Lledo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (12)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.